Iron-Deficiency Anemia (IDA)
This condition is caused by a shortage of this trace element or impaired iron utilization. Key causes include chronic blood loss, increased physiological demand (e.g., pregnancy), and dietary deficiency.
Combination supplements are used for treatment, with ingredients addressing various biochemical needs of erythropoiesis:
- Ferrous sulfate ($FeSO_4$): Provides exogenous divalent iron ($Fe^{2+}$), acting as a direct substrate for heme and hemoglobin synthesis.
- Ascorbic acid (Vitamin C): Acts as a reducing agent in the GI tract, converting $Fe3+$ to the absorbable $Fe^{2+}$ form. It is also required to mobilize iron stores from the intracellular protein ferritin.
- Folic acid (Vitamin $B_9$): Essential for purine and pyrimidine nucleotide (DNA) synthesis, ensuring active proliferation of erythroid progenitor cells.
- Cyanocobalamin (Vitamin $B_{12}$): A cofactor converting folic acid into its active form, tetrahydrofolate. It participates in the conversion of homocysteine to methionine and protects against megaloblastic anemia.
Hemochromatosis (Iron Overload)
A pathology diametrically opposed to deficiency, characterized by excessive iron accumulation. Excess iron is deposited as hemosiderin pigment granules within cells of the reticuloendothelial system, primarily in the liver and spleen.
Hemosiderin accumulation is toxic and eventually leads to severe organ damage. The main causes of such overload include frequent blood transfusions or pathologically increased intestinal iron absorption.
Iron Transport and Stengel-Helmyeyer Disease
Cellular iron uptake is mediated by receptor-mediated endocytosis:
- A transferrin-$Fe^{3+}$ complex binds to a specific cell-surface receptor.
- The membrane invaginates to form an intracellular vesicle (endosome).
- The $H^+$-ATPase pump pumps protons into the endosome, acidifying its interior.
- In the acidic environment, iron dissociates from transferrin and is released into the cytosol for cellular use.
A congenital defect in transferrin synthesis is known as atransferrinemia (Stengel-Helmyeyer disease). This condition creates a paradox: tissues experience severe iron starvation despite adequate or high total body iron.